- Active not recruitingPHASE3
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
This study is looking into a new medication called povorcitinib for people with prurigo nodularis, a skin condition causing very itchy bumps. It aims to see how well it reduces itching and skin problems, and if it's safe to use.
For: Prurigo NodularisUnited States · Australia · Belgium - Active not recruitingPHASE3
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
This study is testing a new medicine called povorcitinib for people with a type of vitiligo called nonsegmental vitiligo. Researchers want to see if it's safe and helps improve the skin patches. It's a Phase 3 trial, meaning it's a later stage of research.
For: NonSegmental VitiligoUnited States · Bulgaria · Canada - RecruitingPHASE3
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
This study is for people who have already taken part in certain Incyte povorcitinib trials for Hidradenitis Suppurativa (HS) and found the treatment helpful. It allows them to continue receiving the study drug if their doctor agrees it's safe and beneficial.
For: Hidradenitis Suppurativa (HS)United States · Argentina · Australia - Active not recruitingPHASE3
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
This study looks at a new medicine called Povorcitinib for moderate to severe hidradenitis suppurativa (HS). It's for people who have already finished an earlier study. We want to see how safe and effective it is over a longer time.
For: Hidradenitis Suppurativa (HS)United States · Australia · Austria